- Home
- NBIX vs SUI Comparison
NBIX vs SUI Comparison
Compare NBIX & SUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- SUI
- Stock Information
- Founded
- NBIX 1992
- SUI 1975
- Country
- NBIX United States
- SUI United States
- Employees
- NBIX N/A
- SUI N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- SUI Real Estate Investment Trusts
- Sector
- NBIX Health Care
- SUI Real Estate
- Exchange
- NBIX Nasdaq
- SUI Nasdaq
- Market Cap
- NBIX 14.1B
- SUI 15.9B
- IPO Year
- NBIX 1996
- SUI 1993
- Fundamental
- Price
- NBIX $139.41
- SUI $128.58
- Analyst Decision
- NBIX Strong Buy
- SUI Buy
- Analyst Count
- NBIX 18
- SUI 14
- Target Price
- NBIX $161.50
- SUI $137.36
- AVG Volume (30 Days)
- NBIX 713.3K
- SUI 811.6K
- Earning Date
- NBIX 10-29-2025
- SUI 11-05-2025
- Dividend Yield
- NBIX N/A
- SUI 3.23%
- EPS Growth
- NBIX 2.97
- SUI 1883.93
- EPS
- NBIX 3.39
- SUI 10.23
- Revenue
- NBIX $2,509,900,000.00
- SUI $3,217,100,000.00
- Revenue This Year
- NBIX $20.66
- SUI N/A
- Revenue Next Year
- NBIX $14.64
- SUI $3.68
- P/E Ratio
- NBIX $41.44
- SUI $12.60
- Revenue Growth
- NBIX 18.42
- SUI 17.94
- 52 Week Low
- NBIX $84.23
- SUI $109.22
- 52 Week High
- NBIX $154.61
- SUI $147.50
- Technical
- Relative Strength Index (RSI)
- NBIX 53.05
- SUI 52.61
- Support Level
- NBIX $140.56
- SUI $128.19
- Resistance Level
- NBIX $144.04
- SUI $131.78
- Average True Range (ATR)
- NBIX 3.54
- SUI 2.18
- MACD
- NBIX -0.26
- SUI 0.08
- Stochastic Oscillator
- NBIX 35.85
- SUI 53.08
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About SUI Sun Communities Inc.
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 502 properties, which includes 337 manufactured housing communities and 165 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.